DocumentCode
3319876
Title
Notice of Retraction
Oral Hypoglycemic Drugs and Hypoglycemic Active Elements from Plants for the Treatment of Diabetes Mellitus: A Review
Author
Zhong Zhang ; Wang-Song Zhang ; Hua Ye ; Fei Wang ; Li-Ping Wei
Author_Institution
Coll. of Chem. & Life Sci., Guangdong Univ. of Petrochem. Technol., Maoming, China
fYear
2011
fDate
10-12 May 2011
Firstpage
1
Lastpage
5
Abstract
Notice of Retraction
After careful and considered review of the content of this paper by a duly constituted expert committee, this paper has been found to be in violation of IEEE´s Publication Principles.
We hereby retract the content of this paper. Reasonable effort should be made to remove all past references to this paper.
The presenting author of this paper has the option to appeal this decision by contacting TPII@ieee.org.
Diabetes mellitus (DM) is a serious endocrine disorder disease affecting the metabolism of carbohydrates, fats and protein. In recent years, the incidence of DM has increased worldwide, especially in developed countries. Two main classes of medicines, oral hypoglycemic drugs (OHD) and hypoglycemic active elements from plants (HAEPs), are used to treat DM by reducing blood sugar levels. OHDs can be classed based on their chemical structures as sulfonylurea compounds, biguanide compounds, α-glucosidase inhibitors, thiazolinediones and repaglindes. HAEPs can also be classed based on their chemical structure as polysaccharides, saponins, flavonoids, alkaloids, terpenoids, peptides, sulfuryl containing compounds, steroids and unsaturated fatty acids. This paper reviews the uses of OHDs and HAEPs for the treatment of DM.
After careful and considered review of the content of this paper by a duly constituted expert committee, this paper has been found to be in violation of IEEE´s Publication Principles.
We hereby retract the content of this paper. Reasonable effort should be made to remove all past references to this paper.
The presenting author of this paper has the option to appeal this decision by contacting TPII@ieee.org.
Diabetes mellitus (DM) is a serious endocrine disorder disease affecting the metabolism of carbohydrates, fats and protein. In recent years, the incidence of DM has increased worldwide, especially in developed countries. Two main classes of medicines, oral hypoglycemic drugs (OHD) and hypoglycemic active elements from plants (HAEPs), are used to treat DM by reducing blood sugar levels. OHDs can be classed based on their chemical structures as sulfonylurea compounds, biguanide compounds, α-glucosidase inhibitors, thiazolinediones and repaglindes. HAEPs can also be classed based on their chemical structure as polysaccharides, saponins, flavonoids, alkaloids, terpenoids, peptides, sulfuryl containing compounds, steroids and unsaturated fatty acids. This paper reviews the uses of OHDs and HAEPs for the treatment of DM.
Keywords
blood; diseases; drugs; patient treatment; pharmaceutical technology; α-glucosidase inhibitor; HAEP; OHD; alkaloids; biguanide compound; blood sugar level; carbohydrate; chemical structure; diabetes mellitus; endocrine disorder disease; fats; flavonoids; hypoglycemic active element; oral hypoglycemic drug; peptide; plants; polysaccharide; protein; repaglindes; saponins; steroid; sulfonylurea compound; sulfuryl containing compound; terpenoids; thiazolinediones; unsaturated fatty acid; Compounds; Delta modulation; Diabetes; Insulin; Rats; Sugar;
fLanguage
English
Publisher
ieee
Conference_Titel
Bioinformatics and Biomedical Engineering, (iCBBE) 2011 5th International Conference on
Conference_Location
Wuhan
ISSN
2151-7614
Print_ISBN
978-1-4244-5088-6
Type
conf
DOI
10.1109/icbbe.2011.5780157
Filename
5780157
Link To Document